Salem Investment Counselors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-19
Closed -$5.41K 1234
2026
Q1
$3.31K Buy
+19
New +$3.89K ﹤0.01% 1020
2025
Q4
Sell
-19
Closed -$4.96K 728
2025
Q3
$4.96K Hold
19
﹤0.01% 984
2025
Q2
$4.66K Hold
19
﹤0.01% 953
2025
Q1
$5.04K Hold
19
﹤0.01% 931
2024
Q4
$4.84K Sell
19
-1
-5% -$268 ﹤0.01% 926
2024
Q3
$6.35K Buy
20
+1
+5% +$356 ﹤0.01% 902
2024
Q2
$7.12K Hold
19
﹤0.01% 874
2024
Q1
$6.61K Hold
19
﹤0.01% 892
2023
Q4
$8.72K Sell
19
-3
-14% -$1.48K ﹤0.01% 842
2023
Q3
$10.7K Buy
22
+3
+16% +$1.41K ﹤0.01% 784
2023
Q2
$8.51K Hold
19
﹤0.01% 852
2023
Q1
$9.24K Hold
19
﹤0.01% 825
2022
Q4
$9.75K Hold
19
﹤0.01% 788
2022
Q3
$9K Buy
+19
New +$9.24K ﹤0.01% 770
2017
Q3
Sell
-24
Closed -$6K 618
2017
Q2
$6K Buy
+24
New +$5.43K ﹤0.01% 504

Other funds holding HUM

Salem Investment Counselors's HUM Position: Q2 2026 in Review

Salem Investment Counselors sold out of Humana (HUM) in Q2 2026, closing a stake of 19 shares — an estimated $5.41K sold.

Salem Investment Counselors first reported a position in HUM in Q2 2017 and held it in 15 quarters. The position peaked at $10.7K in Q3 2023. 339 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Salem Investment Counselors reported no remaining Humana position as of Q2 2026 after selling out during the quarter.
  • Salem Investment Counselors sold 19 Humana shares in Q2 2026, an estimated $5.41K.
  • Salem Investment Counselors first reported a position in Humana in Q2 2017 and held it in 15 quarters.
  • Salem Investment Counselors's Humana position peaked at $10.7K in Q3 2023.
  • 339 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.